Browsing by Author Bill Walsh Cancer Research Laboratories
Showing results 2 to 8 of 8
| Preview | Issue Date | Title | Author(s) |
| 25-Jun-2008 | ERCC1 expression and RAD51B activity correlate with cell cycle response to platinum drug treatment not DNA repair | Stordal, Britta; Davey, Ross; Bill Walsh Cancer Research Laboratories |
| 2007 | Oxaliplatin for the treatment of cisplatin-resistant cancer: a systematic review | Stordal, Britta; Pavlakis, Nick; Davey, Ross; Bill Walsh Cancer Research Laboratories |
| 2006 | Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells | Stordal, Britta K; Davey, Mary W; Davey, Ross A; Bill Walsh Cancer Research Laboratories |
| 2009 | Regrowth resistance: low-level platinum resistance mediated by rapid recovery from platinum-induced cell-cycle arrest | Stordal, Britta; Davey, Ross; Bill Walsh Cancer Research Laboratories |
| 2007 | A systematic review of platinum and taxane resistance from bench to clinic: an inverse relationship | Stordal, Britta; Pavlakis, Nick; Davey, Ross; Bill Walsh Cancer Research Laboratories |
| 2009 | Treating cisplatin-resistant cancer: a systematic analysis of oxaliplatin or paclitaxel salvage chemotherapy. | Stordal, Britta; Pavlakis, Nick; Davey, Ross; Bill Walsh Cancer Research Laboratories |
| 2007 | Understanding cisplatin resistance using cellular models | Stordal, Britta; Davey, Mary; Bill Walsh Cancer Research Laboratories |
Showing results 2 to 8 of 8